JP5932825B2 - グルカンゲル - Google Patents

グルカンゲル Download PDF

Info

Publication number
JP5932825B2
JP5932825B2 JP2013540442A JP2013540442A JP5932825B2 JP 5932825 B2 JP5932825 B2 JP 5932825B2 JP 2013540442 A JP2013540442 A JP 2013540442A JP 2013540442 A JP2013540442 A JP 2013540442A JP 5932825 B2 JP5932825 B2 JP 5932825B2
Authority
JP
Japan
Prior art keywords
glucan
gel
beta
acid
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2013540442A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013544937A (ja
JP2013544937A5 (cg-RX-API-DMAC7.html
Inventor
エングスタッド ロルフ
エングスタッド ロルフ
ソレム ステイン−トレ
ソレム ステイン−トレ
ラムセイ ダグ−エイリック
ラムセイ ダグ−エイリック
Original Assignee
ビオテック ファルマコン アルメン アクスイェ セルスカプ
ビオテック ファルマコン アルメン アクスイェ セルスカプ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ビオテック ファルマコン アルメン アクスイェ セルスカプ, ビオテック ファルマコン アルメン アクスイェ セルスカプ filed Critical ビオテック ファルマコン アルメン アクスイェ セルスカプ
Publication of JP2013544937A publication Critical patent/JP2013544937A/ja
Publication of JP2013544937A5 publication Critical patent/JP2013544937A5/ja
Application granted granted Critical
Publication of JP5932825B2 publication Critical patent/JP5932825B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
JP2013540442A 2010-11-29 2011-11-29 グルカンゲル Expired - Fee Related JP5932825B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1020191.1 2010-11-29
GBGB1020191.1A GB201020191D0 (en) 2010-11-29 2010-11-29 Glucan gels
PCT/GB2011/052358 WO2012073019A1 (en) 2010-11-29 2011-11-29 Glucan gels

Publications (3)

Publication Number Publication Date
JP2013544937A JP2013544937A (ja) 2013-12-19
JP2013544937A5 JP2013544937A5 (cg-RX-API-DMAC7.html) 2014-08-28
JP5932825B2 true JP5932825B2 (ja) 2016-06-08

Family

ID=43500783

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013540442A Expired - Fee Related JP5932825B2 (ja) 2010-11-29 2011-11-29 グルカンゲル

Country Status (8)

Country Link
US (2) US9314432B2 (cg-RX-API-DMAC7.html)
EP (1) EP2646476B1 (cg-RX-API-DMAC7.html)
JP (1) JP5932825B2 (cg-RX-API-DMAC7.html)
KR (1) KR20130121138A (cg-RX-API-DMAC7.html)
CN (1) CN103347899B (cg-RX-API-DMAC7.html)
CA (1) CA2818648C (cg-RX-API-DMAC7.html)
GB (1) GB201020191D0 (cg-RX-API-DMAC7.html)
WO (1) WO2012073019A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT514137A1 (de) 2013-04-05 2014-10-15 Lenzing Akiengesellschaft Polysaccharidfaser und Verfahren zu ihrer Herstellung
AT514468A1 (de) 2013-06-17 2015-01-15 Lenzing Akiengesellschaft Hochsaugfähige Polysaccharidfaser und ihre Verwendung
AT514474B1 (de) 2013-06-18 2016-02-15 Chemiefaser Lenzing Ag Polysaccharidfaser und Verfahren zu ihrer Herstellung
AT518612B1 (de) 2015-02-06 2019-03-15 Chemiefaser Lenzing Ag Polysaccharid-Suspension, Verfahren zu ihrer Herstellung und ihre Verwendung
CN112402443B (zh) * 2019-08-22 2024-12-31 广州立恩生物科技有限公司 用于预防和治疗口腔疾病的生物多糖及其应用
CN111329875B (zh) * 2020-02-26 2023-07-21 好维股份有限公司 用于修复口腔软组织细胞的口腔护理组合物及应用
US11384160B1 (en) 2021-07-30 2022-07-12 Tissue repair ltd Method of making a beta glucan compound
US11572420B1 (en) 2021-07-30 2023-02-07 Tissue repair ltd Isolated biological polysaccharide compound, methods of use and methods of manufacture thereof
CN116239706B (zh) * 2022-10-24 2024-06-21 湖北中医药大学 一种直链茯苓β-葡聚糖及其提取方法和应用
CN116584552B (zh) * 2023-05-19 2024-03-26 江南大学 一种基于葡聚糖自主装交联多维度乳液凝胶的制备及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0490995A1 (en) 1989-09-08 1992-06-24 Alpha Beta Technology Method for producing soluble glucans
US5158772A (en) * 1991-09-23 1992-10-27 Davis Walter B Unique bacterial polysaccharide polymer gel in cosmetics, pharmaceuticals and foods
NO300692B1 (no) 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
US5980918A (en) 1997-10-24 1999-11-09 Brennen Medical, Inc. β-D-glucan topical composition
AU3657100A (en) 1999-03-12 2000-10-04 Biotec Asa Use of water-soluble beta-(1,3) glucans as agents for producing therapeutic skintreatment agents
DE60135658D1 (de) * 2000-07-03 2008-10-16 Granate Seed Ltd In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung
CA2434938C (en) 2001-01-16 2012-02-28 Sloan-Kettering Institute For Cancer Research Compositions of glucan and a monoclonal antibody which exhibit an enhancement of the anti tumor activity of the antibody
GB0225502D0 (en) 2002-11-01 2002-12-11 Zoolife Internat Ltd Therapeutic and prophylactic preparations
CN101394898A (zh) * 2005-11-30 2009-03-25 西巴控股公司 葡聚糖组合物
CN101426510A (zh) * 2006-01-17 2009-05-06 斯隆-凯特林癌症研究院 增强治疗的酵母葡聚糖
US8323644B2 (en) * 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
WO2008102151A1 (en) 2007-02-21 2008-08-28 Biotec Pharmacon Asa Medical uses of glucans
CN101878033A (zh) * 2007-11-13 2010-11-03 生物科技医药公司 治疗或预防肠道炎症性疾病的方法
CN101353383B (zh) * 2008-09-17 2010-12-08 山东京博控股发展有限公司 水溶性酵母β-葡聚糖及其制备方法

Also Published As

Publication number Publication date
CA2818648A1 (en) 2012-06-07
KR20130121138A (ko) 2013-11-05
EP2646476B1 (en) 2017-01-25
JP2013544937A (ja) 2013-12-19
US9750688B2 (en) 2017-09-05
WO2012073019A1 (en) 2012-06-07
CA2818648C (en) 2016-11-15
CN103347899A (zh) 2013-10-09
CN103347899B (zh) 2016-08-17
US20130315979A1 (en) 2013-11-28
US20160256385A1 (en) 2016-09-08
GB201020191D0 (en) 2011-01-12
US9314432B2 (en) 2016-04-19
EP2646476A1 (en) 2013-10-09

Similar Documents

Publication Publication Date Title
JP6027013B2 (ja) グルカン組成物
US9750688B2 (en) Glucan gels
JP5932824B2 (ja) グルカン
AU2022316595A1 (en) Isolated polysaccharide compound and method of use and manufacture
AU2013203451B8 (en) Glucan Gels

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140710

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140710

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150324

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150623

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150819

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20151020

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160210

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20160303

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160329

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160428

R150 Certificate of patent or registration of utility model

Ref document number: 5932825

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees